XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses:        
Research and development $ 4,258 $ 5,989 $ 21,287 $ 16,443
General and administrative 4,490 3,394 14,294 8,526
Total operating expenses 8,748 9,383 35,581 24,969
Loss from operations (8,748) (9,383) (35,581) (24,969)
Other income (expense):        
Change in fair value of redeemable convertible preferred stock tranche liability 0 0 0 (11,718)
Foreign currency loss (1,317) (252) (2,516) (268)
Other income, net 383 20 615 20
Total other income (expense) (934) (232) (1,901) (11,966)
Net loss (9,682) (9,615) (37,482) (36,935)
Accretion of redeemable convertible preferred stock to redemption value and cumulative preferred stock dividends 0 (1,322) 0 (4,548)
Net loss attributable to common stockholders $ (9,682) $ (10,937) $ (37,482) $ (41,483)
Net loss per share attributable to common stockholders, Basic $ (0.37) $ (0.70) $ (1.43) $ (5.49)
Net loss per share attributable to common stockholders, Diluted $ (0.37) $ (0.70) $ (1.43) $ (5.49)
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic 26,336,029 15,585,611 26,290,868 7,554,300
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted 26,336,029 15,585,611 26,290,868 7,554,300
Comprehensive loss:        
Net loss $ (9,682) $ (9,615) $ (37,482) $ (36,935)
Other comprehensive loss        
Unrealized gain (loss) on investments 23 18 (458) (18)
Comprehensive loss $ (9,659) $ (9,633) $ (37,940) $ (36,953)